<p>无论他们的投资风格如何——成长、价值、收入或其他——每个人都喜欢超越市场。然而，在相对较长的时间内做到这一点并不容易。这就是为什么那些能够持续做到这一点的对冲基金经理会成为华尔街的大牌。</p>
<p>好消息是，即使是那些没有被支付来挑选股票的普通投资者也仍然可以超越市场。为了帮助你实现这一目标，让我们讨论两家可能在 2031 年前提供超出平均回报的公司：<strong>Intuitive Surgical</strong>（ISRG 1.04%）和 <strong>Meta Platforms</strong>（META 0.88%）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg0ODY2Ni9waHlzaWNpYW5zLWluLWFuLW9wZXJhdGluZy1yb29tLmpwZxZ3PTM4NDAWb3A9cmVzaXpl?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg0ODY2Ni9waHlzaWNpYW5zLWluLWFuLW9wZXJhdGluZy1yb29tLmpwZxZ3PTM4NDAWb3A9cmVzaXpl"/></p>
<p>图片来源：Getty Images。</p>
<h2>1. Intuitive Surgical</h2>
<p>公平地说，Intuitive Surgical 在过去 12 个月的表现并不理想。增加的 关税 正在影响其财务结果，而它主导的机器人辅助手术（RAS）细分市场的竞争也在加剧。然而，未来几年内，有几个因素可能会推动 Intuitive Surgical 的股票大幅上涨。其中之一是其达芬奇系统最新版本的推出，目前已进入第五代。每一代都比前一代更好，这次也不例外。</p>
<p>最新达芬奇系统的一个关键新特性是力反馈技术，使外科医生在手术过程中能够更好地感知施加在患者组织上的压力，从而在必要时进行调整，以避免损伤和创伤。</p>
<p>这可能会为患者带来更好的结果，这将有助于增加对公司技术的需求，无论是来自医疗服务提供者还是消费者。这个达芬奇系统仍然很新——它是在去年推出的，并且反响良好。不过，我们仍处于这个故事的早期阶段。</p>
<p>广告</p>
<p>另一个推动 Intuitive Surgical 增长的重要因素应该是针对新适应症的批准，这有助于提高其手术量，这是收入增长的重要驱动力。Intuitive Surgical 最近宣布了其达芬奇系统的三个新批准。</p>
<p>展开</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvSVNSRy5wbmcWdz0xMjgWb3A9cmVzaXpl?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="Intuitive Surgical 股票报价" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvSVNSRy5wbmcWdz0xMjgWb3A9cmVzaXpl"/></p>
<h2>NASDAQ: ISRG</h2>
<p>Intuitive Surgical</p>
<p>今日变动</p>
<p>(-1.04%) $-5.95</p>
<p>当前价格</p>
<p>$566.68</p>
<h3>关键数据点</h3>
<p>市值</p>
<p>$2030 亿</p>
<p>日内区间</p>
<p>$566.00 - $573.49</p>
<p>52 周区间</p>
<p>$425.00 - $616.00</p>
<p>成交量</p>
<p>34K</p>
<p>平均成交量</p>
<p>2.1M</p>
<p>毛利率</p>
<p>66.37%</p>
<p>这一切都很好，但公司能否解决其面临的挑战？可以，而且这样做可能会刺激其股票。关税带来了风险，包括成本增加、利润下降和利润率缩小。Intuitive Surgical 可以通过几种方式来应对这个问题，最显著的是提高价格。由于其一流的设备，公司受益于 定价权，这些设备已被证明能改善患者结果。</p>
<p>凭借庞大的已安装基础，适度的普遍提价可能会产生显著影响。如果关税威胁持续存在，我认为 Intuitive Surgical 最终会采取多管齐下的方法来应对，包括利用其定价权。</p>
<p>竞争情况如何？<strong>Medtronic</strong>，一家 医疗设备领导者，最近获得了美国对其 Hugo 系统在泌尿科手术中的批准，但它可能需要 数年时间 才能对 Intuitive Surgical 构成重大挑战。</p>
<p>此外，由于 RAS 市场尚未充分渗透，因此有多个赢家的空间。因此，Intuitive Surgical 的前景稳健，可能使其在 2031 年前超越更广泛的股票。</p>
<h2>2. Meta Platforms</h2>
<p>Meta Platforms 的股票在发布第三季度财报后最近下跌。其业绩相当强劲，但市场越来越担心 Meta 在 人工智能（AI）上的巨大投资——它计划投入更多资金——可能不会带来回报。然而，该公司在 AI 方面的工作迄今为止已经做出了重要贡献。Meta Platforms 的 AI 驱动算法提升了其网站和应用的参与度，并且该公司基于 AI 的努力自动化了大部分广告发布过程，收入和收益迅速增长。</p>
<p>Meta Platforms 还有更大的雄心。例如，该公司希望在 2026 年底之前完全自动化广告活动。考虑到这家科技巨头拥有超过 30 亿的日活跃用户，其努力应该会继续带来回报。</p>
<p>展开</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvTUVUQS5wbmcWdz0xMjgWb3A9cmVzaXpl?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="Meta Platforms 股票报价" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvTUVUQS5wbmcWdz0xMjgWb3A9cmVzaXpl"/></p>
<h2>NASDAQ: META</h2>
<p>Meta Platforms</p>
<p>今日变动</p>
<p>(-0.88%) $-5.86</p>
<p>当前价格</p>
<p>$660.09</p>
<h3>关键数据点</h3>
<p>市值</p>
<p>$1.7 万亿</p>
<p>日内区间</p>
<p>$659.44 - $665.00</p>
<p>52 周区间</p>
<p>$479.80 - $796.25</p>
<p>成交量</p>
<p>7.9M</p>
<p>平均成交量</p>
<p>18M</p>
<p>毛利率</p>
<p>82.00%</p>
<p>股息收益率</p>
<p>0.32%</p>
<p>但如果它们无法匹配公司所做的投资水平呢？值得注意的是，这种情况以前发生过。Meta Platforms 之所以获得现在的名称，部分是因为它当时专注于构建和货币化 元宇宙，这一雄心并没有如管理层所希望的那样实现。</p>
<p>面对不断增加的开支和收入增长放缓，部分原因是其在元宇宙的投资和更广泛的经济挑战，Meta Platforms 能够控制成本，重新聚焦于其高利润的广告业务，并最终成为一家更强大的公司。换句话说，该公司有足够的灵活性来应对市场担心在未来几年内发生的挑战性局面。</p>
<p>与此同时，其财务业绩应保持强劲，推动其股价上涨。这些都是 Meta Platforms 能够在 2031 年前超越市场的良好理由。</p>

直觉外科

<p>本文讨论了两只成长股，直觉外科和 Meta Platforms，预计它们将在 2031 年前表现优于市场。尽管面临近期挑战，直觉外科凭借其新推出的达芬奇系统和定价能力，仍有增长潜力。Meta Platforms 虽然在其人工智能投资方面受到审查，但其收入增长强劲，商业模式灵活。两家公司在未来几年都有可能实现超出平均水平的回报</p>

<p>Whatever their investing style -- growth, value, income, or other -- everyone loves beating the market. However, doing so over a relatively long period is no easy feat. That's why hedge fund managers who consistently pull it off become big names on Wall Street.</p>
<div class="lb-trans"><p>无论他们的投资风格如何——成长、价值、收入或其他——每个人都喜欢超越市场。然而，在相对较长的时间内做到这一点并不容易。这就是为什么那些能够持续做到这一点的对冲基金经理会成为华尔街的大牌。</p>
</div><p>The good news is that even average investors who aren't paid to pick stocks can still beat the market. To help you achieve that, let's discuss two corporations that might deliver above-average returns through 2031: <strong>Intuitive Surgical</strong>( ISRG 1.04%) and <strong>Meta Platforms</strong>( META 0.88%).</p>
<div class="lb-trans"><p>好消息是，即使是那些没有被支付来挑选股票的普通投资者也仍然可以超越市场。为了帮助你实现这一目标，让我们讨论两家可能在 2031 年前提供超出平均回报的公司：<strong>Intuitive Surgical</strong>（ISRG 1.04%）和 <strong>Meta Platforms</strong>（META 0.88%）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84NDg2NjYvcGh5c2ljaWFucy1pbi1hbi1vcGVyYXRpbmctcm9vbS5qcGcmdz0zODQw" alt="Surgeons performing an operation." original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F848666%2Fphysicians-in-an-operating-room.jpg&amp;w=3840&amp;op=resize"/></p>
<p>Image source: Getty Images.</p>
<div class="lb-trans"><p>图片来源：Getty Images。</p>
</div><h2>1. Intuitive Surgical</h2>
<div class="lb-trans"><h2>1. Intuitive Surgical</h2>
</div><p>In fairness, Intuitive Surgical hasn't had a great past 12 months. Increased tariffs are affecting its financial results, and competition in its robotic-assisted surgery (RAS) niche, which it dominates, is intensifying. However, several things could drive Intuitive Surgical's stock much higher in the next few years. One of them is the launch of the newest version of its da Vinci system, which is now in its fifth iteration. Each has been better than the last, and this time is no different.</p>
<div class="lb-trans"><p>公平地说，Intuitive Surgical 在过去 12 个月的表现并不理想。增加的 关税 正在影响其财务结果，而它主导的机器人辅助手术（RAS）细分市场的竞争也在加剧。然而，未来几年内，有几个因素可能会推动 Intuitive Surgical 的股票大幅上涨。其中之一是其达芬奇系统最新版本的推出，目前已进入第五代。每一代都比前一代更好，这次也不例外。</p>
</div><p>One key new feature of the latest da Vinci system is Force Feedback Technology, which enables surgeons to have a better sense of the pressure they are exerting on patients' tissue during procedures, allowing them to make adjustments as needed to avoid damage and trauma.</p>
<div class="lb-trans"><p>最新达芬奇系统的一个关键新特性是力反馈技术，使外科医生在手术过程中能够更好地感知施加在患者组织上的压力，从而在必要时进行调整，以避免损伤和创伤。</p>
</div><p>This could lead to even better outcomes for patients, something that will help increase demand for the company's technology, both from healthcare providers and consumers. This da Vinci system is still new -- it was only launched last year and has been well-received. We're still in the early innings of this story, though.</p>
<div class="lb-trans"><p>这可能会为患者带来更好的结果，这将有助于增加对公司技术的需求，无论是来自医疗服务提供者还是消费者。这个达芬奇系统仍然很新——它是在去年推出的，并且反响良好。不过，我们仍处于这个故事的早期阶段。</p>
</div><p>Advertisement</p>
<div class="lb-trans"><p>广告</p>
</div><p>Another important growth driver for Intuitive Surgical should be approvals across newer indications, which help boost its procedure volume, an important driver of revenue growth. Intuitive Surgical recently announced three new approvals for one of its da Vinci systems.</p>
<div class="lb-trans"><p>另一个推动 Intuitive Surgical 增长的重要因素应该是针对新适应症的批准，这有助于提高其手术量，这是收入增长的重要驱动力。Intuitive Surgical 最近宣布了其达芬奇系统的三个新批准。</p>
</div><p>Expand</p>
<div class="lb-trans"><p>展开</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vYXJ0L2NvbXBhbnlsb2dvcy9tYXJrL0lTUkcucG5nJnc9MTI4" alt="Intuitive Surgical Stock Quote" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Fart%2Fcompanylogos%2Fmark%2FISRG.png&amp;w=128&amp;op=resize"/></p>
<h2>NASDAQ: ISRG</h2>
<div class="lb-trans"><h2>NASDAQ: ISRG</h2>
</div><p>Intuitive Surgical</p>
<div class="lb-trans"><p>Intuitive Surgical</p>
</div><p>Today's Change</p>
<div class="lb-trans"><p>今日变动</p>
</div><p>(-1.04%) $-5.95</p>
<div class="lb-trans"><p>(-1.04%) $-5.95</p>
</div><p>Current Price</p>
<div class="lb-trans"><p>当前价格</p>
</div><p>$566.68</p>
<div class="lb-trans"><p>$566.68</p>
</div><h3>Key Data Points</h3>
<div class="lb-trans"><h3>关键数据点</h3>
</div><p>Market Cap</p>
<div class="lb-trans"><p>市值</p>
</div><p>$203B</p>
<div class="lb-trans"><p>$2030 亿</p>
</div><p>Day's Range</p>
<div class="lb-trans"><p>日内区间</p>
</div><p>$566.00 - $573.49</p>
<div class="lb-trans"><p>$566.00 - $573.49</p>
</div><p>52wk Range</p>
<div class="lb-trans"><p>52 周区间</p>
</div><p>$425.00 - $616.00</p>
<div class="lb-trans"><p>$425.00 - $616.00</p>
</div><p>Volume</p>
<div class="lb-trans"><p>成交量</p>
</div><p>34K</p>
<div class="lb-trans"><p>34K</p>
</div><p>Avg Vol</p>
<div class="lb-trans"><p>平均成交量</p>
</div><p>2.1M</p>
<div class="lb-trans"><p>2.1M</p>
</div><p>Gross Margin</p>
<div class="lb-trans"><p>毛利率</p>
</div><p>66.37%</p>
<div class="lb-trans"><p>66.37%</p>
</div><p>That's all well and good, but can the company address its challenges? It can, and doing so may jolt its stock. Tariffs pose dangers, including increased costs, lower profits, and narrower margins. Intuitive Surgical could get around that problem in several ways, most notably by increasing its prices. The company benefits from pricing power due to its best-in-class devices, which have been proven to improve patient outcomes.</p>
<div class="lb-trans"><p>这一切都很好，但公司能否解决其面临的挑战？可以，而且这样做可能会刺激其股票。关税带来了风险，包括成本增加、利润下降和利润率缩小。Intuitive Surgical 可以通过几种方式来应对这个问题，最显著的是提高价格。由于其一流的设备，公司受益于 定价权，这些设备已被证明能改善患者结果。</p>
</div><p>With a large installed base, relatively modest price hikes across the board could have a meaningful effect. If the threat of tariffs persists, my view is that Intuitive Surgical will eventually adopt a multipronged approach to addressing it, including leveraging its pricing power.</p>
<div class="lb-trans"><p>凭借庞大的已安装基础，适度的普遍提价可能会产生显著影响。如果关税威胁持续存在，我认为 Intuitive Surgical 最终会采取多管齐下的方法来应对，包括利用其定价权。</p>
</div><p>What about competition? <strong>Medtronic</strong>, a medical device leader, recently earned approval in the U.S. for its Hugo system in urologic procedures, but it will likely take years before it poses a significant challenge to Intuitive Surgical.</p>
<div class="lb-trans"><p>竞争情况如何？<strong>Medtronic</strong>，一家 医疗设备领导者，最近获得了美国对其 Hugo 系统在泌尿科手术中的批准，但它可能需要 数年时间 才能对 Intuitive Surgical 构成重大挑战。</p>
</div><p>Besides, since the RAS market is underpenetrated, there is room for multiple winners. Therefore, Intuitive Surgical's outlook is robust and could enable it to outperform broader equities through 2031.</p>
<div class="lb-trans"><p>此外，由于 RAS 市场尚未充分渗透，因此有多个赢家的空间。因此，Intuitive Surgical 的前景稳健，可能使其在 2031 年前超越更广泛的股票。</p>
</div><h2>2. Meta Platforms</h2>
<div class="lb-trans"><h2>2. Meta Platforms</h2>
</div><p>Meta Platforms' shares recently dropped after it released its third-quarter earnings. Its results were fairly strong, but the market is increasingly worried that Meta's huge investments in artificial intelligence (AI) -- where it is planning to pour even more funds -- may not pay off. However, the company's work in AI has made meaningful contributions so far. Between Meta Platforms' AI-powered algorithms boosting engagement across its websites and apps, and the company's AI-based efforts to automate much of the ad launch process, revenue and earnings have been growing rapidly.</p>
<div class="lb-trans"><p>Meta Platforms 的股票在发布第三季度财报后最近下跌。其业绩相当强劲，但市场越来越担心 Meta 在 人工智能（AI）上的巨大投资——它计划投入更多资金——可能不会带来回报。然而，该公司在 AI 方面的工作迄今为止已经做出了重要贡献。Meta Platforms 的 AI 驱动算法提升了其网站和应用的参与度，并且该公司基于 AI 的努力自动化了大部分广告发布过程，收入和收益迅速增长。</p>
</div><p>Meta Platforms has even bigger ambitions. The company wants to completely automate ad campaigns by the end of 2026, for instance. Given the tech leader's large ecosystem of more than 3 billion daily active users, its efforts should continue paying off.</p>
<div class="lb-trans"><p>Meta Platforms 还有更大的雄心。例如，该公司希望在 2026 年底之前完全自动化广告活动。考虑到这家科技巨头拥有超过 30 亿的日活跃用户，其努力应该会继续带来回报。</p>
</div><p>Expand</p>
<div class="lb-trans"><p>展开</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vYXJ0L2NvbXBhbnlsb2dvcy9tYXJrL01FVEEucG5nJnc9MTI4" alt="Meta Platforms Stock Quote" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Fart%2Fcompanylogos%2Fmark%2FMETA.png&amp;w=128&amp;op=resize"/></p>
<h2>NASDAQ: META</h2>
<div class="lb-trans"><h2>NASDAQ: META</h2>
</div><p>Meta Platforms</p>
<div class="lb-trans"><p>Meta Platforms</p>
</div><p>Today's Change</p>
<div class="lb-trans"><p>今日变动</p>
</div><p>(-0.88%) $-5.86</p>
<div class="lb-trans"><p>(-0.88%) $-5.86</p>
</div><p>Current Price</p>
<div class="lb-trans"><p>当前价格</p>
</div><p>$660.09</p>
<div class="lb-trans"><p>$660.09</p>
</div><h3>Key Data Points</h3>
<div class="lb-trans"><h3>关键数据点</h3>
</div><p>Market Cap</p>
<div class="lb-trans"><p>市值</p>
</div><p>$1.7T</p>
<div class="lb-trans"><p>$1.7 万亿</p>
</div><p>Day's Range</p>
<div class="lb-trans"><p>日内区间</p>
</div><p>$659.44 - $665.00</p>
<div class="lb-trans"><p>$659.44 - $665.00</p>
</div><p>52wk Range</p>
<div class="lb-trans"><p>52 周区间</p>
</div><p>$479.80 - $796.25</p>
<div class="lb-trans"><p>$479.80 - $796.25</p>
</div><p>Volume</p>
<div class="lb-trans"><p>成交量</p>
</div><p>7.9M</p>
<div class="lb-trans"><p>7.9M</p>
</div><p>Avg Vol</p>
<div class="lb-trans"><p>平均成交量</p>
</div><p>18M</p>
<div class="lb-trans"><p>18M</p>
</div><p>Gross Margin</p>
<div class="lb-trans"><p>毛利率</p>
</div><p>82.00%</p>
<div class="lb-trans"><p>82.00%</p>
</div><p>Dividend Yield</p>
<div class="lb-trans"><p>股息收益率</p>
</div><p>0.32%</p>
<div class="lb-trans"><p>0.32%</p>
</div><p>But what if they don't match the level of investments the company is making? It's worth noting that something like this has happened before. Meta Platforms got its current name partly due to its then-focus on building and monetizing the metaverse, an ambition that never quite materialized, at least not anywhere near the level management had hoped.</p>
<div class="lb-trans"><p>但如果它们无法匹配公司所做的投资水平呢？值得注意的是，这种情况以前发生过。Meta Platforms 之所以获得现在的名称，部分是因为它当时专注于构建和货币化 元宇宙，这一雄心并没有如管理层所希望的那样实现。</p>
</div><p>When faced with mounting expenses and declining revenue growth, partly due to its metaverse investments and broader economic challenges, Meta Platforms was able to rein in costs, refocus on its highly profitable advertising business, and ultimately emerge as a stronger company. In other words, the corporation has enough flexibility to handle the kind of challenging situation the market fears will happen in a few years.</p>
<div class="lb-trans"><p>面对不断增加的开支和收入增长放缓，部分原因是其在元宇宙的投资和更广泛的经济挑战，Meta Platforms 能够控制成本，重新聚焦于其高利润的广告业务，并最终成为一家更强大的公司。换句话说，该公司有足够的灵活性来应对市场担心在未来几年内发生的挑战性局面。</p>
</div><p>Meanwhile, its financial results should remain robust, driving its stock price higher. These are all good reasons that Meta Platforms can beat the market through 2031.</p>
<div class="lb-trans"><p>与此同时，其财务业绩应保持强劲，推动其股价上涨。这些都是 Meta Platforms 能够在 2031 年前超越市场的良好理由。</p>
</div>

Prediction: These 2 Growth Stocks Will Beat the Market Through 2031

- Intuitive Surgical 和 Meta Platforms 被认为可能在 2031 年实现超额回报。  
- Intuitive Surgical 正面临关税等挑战，但新产品和审批将推动增长。  
- Meta Platforms 通过 AI 技术提升广告收入，有潜力应对市场挑战。

预测：这两只成长型股票将在 2031 年前超越市场表现